JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 15, 2006; DOI: 10.1124/jpet.106.108126


0022-3565/07/3203-1097-1105$20.00
JPET 320:1097-1105, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.108126v1
320/3/1097    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiley, J. L.
Right arrow Articles by Wright, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiley, J. L.
Right arrow Articles by Wright, M. J., Jr.

NEUROPHARMACOLOGY

Pharmacological Effects of Acute and Repeated Administration of {Delta}9-Tetrahydrocannabinol in Adolescent and Adult Rats

Jenny L. Wiley, Mary M. O'Connell, Mary E. Tokarz, and M. Jerry Wright, Jr.

Departments of Pharmacology and Toxicology (J.L.W., M.M.O., M.E.T.) and Psychology (J.L.W., M.J.W.), Virginia Commonwealth University, Richmond, Virginia

Adolescents of many mammalian species exhibit rapid physiological change that is accompanied by behaviors such as increased risk taking and social interaction with peers. Marijuana abusers frequently report that their initial use occurred during adolescence. Our goal was to determine whether the in vivo effects of {Delta}9-tetrahydrocannabinol ({Delta}9-THC) differed in adolescent and adult rats. Following initial testing with {Delta}9-THC in adolescent [postnatal day (PN)29] and adult (>PN60) rats of both sexes, we injected rats twice daily with 10 mg/kg {Delta}9-THC or vehicle for 9.5 days. Subsequently, rats were again injected with their initial dose of {Delta}9-THC and tested. In all rats, {Delta}9-THC produced dose-dependent locomotor suppression, antinociception, hypothermia and catalepsy. Some age-dependent differences in potency and efficacy were noted. Although {Delta}9-THC dose-effect functions were more similar across age after repeated exposure, subchronic dosing produced greater change in the hypothermic and locomotor effects of {Delta}9-THC in adolescents, but less change in its antinociceptive effects. These results suggest that the effects of initial exposure to {Delta}9-THC may not be entirely predictive of the effects of repeated exposure. Despite similarities in pharmacological effects of {Delta}9-THC after repeated use, adolescents and adults may exhibit differences in the pattern of transition from use to abuse.


Received May 21, 2006; accepted December 14, 2006.

Address correspondence to: Dr. Jenny Wiley, Department of Pharmacology and Toxicology, Virginia Commonwealth University, P.O. Box 980613, Richmond, VA 23298-0613. E-mail: jwiley{at}vcu.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.